Sign in

CIK 0001018735 · Accelerated filer

NYMOX PHARMACEUTICAL CORP

Sign in to watch
Ticker
NYMXF
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Entity type
other
Phone
1-800-936-9669
Business address
9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC CANADA, Quebec, Canada, H4M 2V2
  1. 6-K Event Report of Foreign Issuer
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. 6-K Event Report of Foreign Issuer
  10. 6-K Event Report of Foreign Issuer
  11. 6-K Event Report of Foreign Issuer
  12. 6-K/A Event Report of Foreign Issuer
  13. 6-K Event Report of Foreign Issuer
  14. 6-K Event Report of Foreign Issuer
  15. 20-F Report Annual and Transition Report of Foreign Private Issuers
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 6-K Event Report of Foreign Issuer
  18. UPLOAD Other SEC-generated Letter
  19. 6-K Event Report of Foreign Issuer
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 13 of 21 · 408 filings